Teva posts strong Q2 earnings and cash flow as turnaround continues

Teva Pharmaceutical Industries (NYSE:TEVA) Q2 results:

Revenues: $3,870M (-7.3%), Generics: $2,086M (-8.5%).

Net income: $140M (+120.3%); non-GAAP net income: $605M (-7.4%); EPS: $0.13 (+120.6%); non-GAAP EPS: $0.55 (-8.3%).

Cash flow ops: $273M (+220.3%).

Debt reduced to $23.9B.

https://seekingalpha.com/news/3600659-teva-posts-strong-q2-earnings-and-cash-flow-turnround-continues